loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 93902b00 6cbf 477d 9a3a E47b2c45ff96 Applno 21306 Form Film Extended Release Transdermal Dosage 7 5mcg Hr - Drug Product Composition: Buprenorphine

    Menu

    Buprenorphine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 21,065Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21306 / DOSAGE - FILM, EXTENDED RELEASE;TRANSDERMAL - 7.5MCG/HR

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    buprenorphine(UNII: 40D3SCR4GZ)
    (buprenorphine - UNII:40D3SCR4GZ)     		buprenorphine20ug in 1 | 10ug in 1 | 5ug in 1

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions LLC
    Lake Erie Medical DBA Quality Care Products LLC
    Purdue Pharma LP
    Rhodes Pharmaceuticals L.P.
    Teva Pharmaceuticals USA, Inc.
    Apotex Corp.
    Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC
    ETHYL LEVULINATE(7BU24CSS2G)  
    Levulinic Acid(RYX5QG61EI)     
    OLEYL OLEATE(3X3L452Y85)
    povidone(FZ989GH94E)     
    POVIDONE, UNSPECIFIED(FZ989GH94E)